A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study-Reference-Cited by-同舟云学术

A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study

Published:2014-05-23 Issue:1 Volume:14 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Stryjewski Martin E,Lentnek Arnold,O’Riordan William,Pullman John,Tambyah Paul Anantharajah,Miró Jose M,Fowler Jr Vance G,Barriere Steven L,Kitt Michael M,Corey G Ralph

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/1471-2334-14-289.pdf

Reference28 articles.

1. Chu VH, Crosslin DR, Friedman JY, Reed SD, Cabell CH, Griffiths RI, Masselink LE, Kaye KS, Corey GR, Reller LB, Stryjewski ME, Schulman KA, Fowler VG: Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am J Med. 2005, 118 (12): 1416-

2. Fowler VG, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, Cheng AC, Dudley T, Oddone EZ: Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003, 163 (17): 2066-2072. 10.1001/archinte.163.17.2066.

3. Li Y, Friedman JY, O’Neal BF, Hohenboken MJ, Griffiths RI, Stryjewski ME, Middleton JP, Schulman KA, Inrig JK, Fowler VG, Reed SD: Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients. Clin J Am Soc Nephrol. 2009, 4 (2): 428-434. 10.2215/CJN.03760708.

4. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK, Active Bacterial Core surveillance (ABCs) MRSA Investigators: Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007, 298 (15): 1763-1771. 10.1001/jama.298.15.1763.

5. Deresinski S: Counterpoint: vancomycin and Staphylococcus aureus–an antibiotic enters obsolescence. Clin Infect Dis. 2007, 44 (12): 1543-1548. 10.1086/518452.

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Antibiotics in the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections: A Systematic Review and Network Meta-Analysis;Antibiotics;2024-09-10

2. Is it time to join the oral antibiotics bandwagon?;The Lancet Infectious Diseases;2024-05

3. Factors for mortality in patients with persistent Staphylococcus aureus bacteremia: The importance of treatment response rather than bacteremia duration;Journal of Microbiology, Immunology and Infection;2023-10

4. Efficacy and safety of vancomycin for the treatment of Staphylococcus aureus bacteraemia: a systematic review and meta-analysis;International Journal of Antimicrobial Agents;2023-10

5. Antibiotics and Carbohydrate-Containing Drugs Targeting Bacterial Cell Envelopes: An Overview;Pharmaceuticals;2022-07-29